{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:11:28Z","timestamp":1649182288339},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.lpm.2016.05.022","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T11:23:34Z","timestamp":1467458614000},"page":"865-870","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prise en charge du patient hyperglyc\u00e9mique\/diab\u00e9tique au cours et au d\u00e9cours imm\u00e9diat d\u2019un syndrome coronaire aigu"],"prefix":"10.1016","volume":"45","author":[{"given":"Bruno","family":"Verg\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lpm.2016.05.022_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"issue":"9733","key":"10.1016\/j.lpm.2016.05.022_bib0145","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood-glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"9324","key":"10.1016\/j.lpm.2016.05.022_bib0150","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.lpm.2016.05.022_bib0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2796.2004.01371.x","article-title":"Abnormal glucose tolerance\u00a0\u2013\u00a0a common risk factor in patients with acute myocardial infarction in comparison with population-based controls","volume":"256","author":"Bartnik","year":"2004","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.lpm.2016.05.022_bib0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/hrt.2006.097956","article-title":"Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission","volume":"93","author":"Norhammar","year":"2007","journal-title":"Heart Br Card Soc"},{"issue":"6","key":"10.1016\/j.lpm.2016.05.022_bib0165","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2006-2584","article-title":"Impact of fasting glycemia on short-term prognosis after acute myocardial infarction","volume":"92","author":"Verg\u00e8s","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2016.05.022_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diabet.2011.11.003","article-title":"Consensus statement on the care of the hyperglycaemic\/diabetic patient during and in the immediate follow-up of acute coronary syndrome","volume":"38","author":"Verg\u00e8s","year":"2012","journal-title":"Diabetes Metab"},{"issue":"8","key":"10.1016\/j.lpm.2016.05.022_bib0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.107.740498","article-title":"Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk","volume":"117","author":"Kosiborod","year":"2008","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.lpm.2016.05.022_bib0180","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/eurheartj\/ehl271","article-title":"Is admission hyperglycaemia in nondiabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?","volume":"27","author":"Ishihara","year":"2006","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2016.05.022_bib0185","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1055\/s-0029-1240928","article-title":"A European evidence-based guideline for the prevention of type 2 diabetes","volume":"42","author":"Paulweber","year":"2010","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.lpm.2016.05.022_bib0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/dc07-1552","article-title":"Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study","volume":"31","author":"Wallander","year":"2008","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.lpm.2016.05.022_bib0195","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.2337\/diacare.26.10.2770","article-title":"Diabetes, insulin-resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes","volume":"26","author":"Tenerz","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.lpm.2016.05.022_bib0200","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s00125-010-1906-6","article-title":"Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study","volume":"53","author":"Andersson","year":"2010","journal-title":"Diabetologia"},{"issue":"9131","key":"10.1016\/j.lpm.2016.05.022_bib0205","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet Lond Engl"},{"issue":"21","key":"10.1016\/j.lpm.2016.05.022_bib0210","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/archinternmed.2010.409","article-title":"Metformin use and mortality among patients with diabetes and atherothrombosis","volume":"170","author":"Roussel","year":"2010","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.lpm.2016.05.022_bib0215","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00125-011-2084-x","article-title":"Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study","volume":"54","author":"Mellbin","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.lpm.2016.05.022_bib0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lpm.2016.05.022_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0195-668X(03)00468-8","article-title":"Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies","volume":"25","author":"Hanefeld","year":"2004","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.lpm.2016.05.022_bib0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.lpm.2016.05.022_bib0235","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.lpm.2016.05.022_bib0240","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.lpm.2016.05.022_bib0245","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lpm.2016.05.022_bib0250","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.2337\/dc14-0908","article-title":"Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study","volume":"37","author":"Bedenis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lpm.2016.05.022_bib0255","doi-asserted-by":"crossref","first-page":"f4533","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lpm.2016.05.022_bib0260","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc14-0920","article-title":"Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study","volume":"38","author":"Khunti","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2016.05.022_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJR.0b013e3283313592","article-title":"Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation","volume":"17","author":"Piepoli","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"11","key":"10.1016\/j.lpm.2016.05.022_bib0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","article-title":"Exercise capacity and mortality among men referred for exercise testing","volume":"346","author":"Myers","year":"2002","journal-title":"N Engl J Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T20:23:06Z","timestamp":1536610986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216301555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0755498216301555"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.022","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge du patient hyperglyc\u00e9mique\/diab\u00e9tique au cours et au d\u00e9cours imm\u00e9diat d\u2019un syndrome coronaire aigu","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}